Developmental and Functional Control of Natural Killer Cells by Cytokines

Overview

Journal Front Immunol

Specialty Allergy & Immunology

Date 2017 Aug 22

PMID 28824650

Citations 144

Authors

Yang Wu

Zhigang Tian

Haiming Wei

Affiliations

Soon will be listed here.

Abstract

Natural killer (NK) cells are effective in combating infections and tumors and as such are tempting for adoptive transfer therapy. However, they are not homogeneous but can be divided into three main subsets, including cytotoxic, tolerant, and regulatory NK cells, with disparate phenotypes and functions in diverse tissues. The development and functions of such NK cells are controlled by various cytokines, such as fms-like tyrosine kinase 3 ligand (FL), kit ligand (KL), interleukin (IL)-3, IL-10, IL-12, IL-18, transforming growth factor-β, and common-γ chain family cytokines, which operate at different stages by regulating distinct signaling pathways. Nevertheless, the specific roles of each cytokine that regulates NK cell development or that shapes different NK cell functions remain unclear. In this review, we attempt to describe the characteristics of each cytokine and the existing protocols to expand NK cells using different combinations of cytokines and feeder cells. A comprehensive understanding of the role of cytokines in NK cell development and function will aid the generation of better efficacy for adoptive NK cell treatment.

Citing Articles

Modeling human natural killer cell development and drug response in a microfluidic bone marrow model.

Koenig L, Ben-Eliezer I, Tao T, Winter A, Grossman M Front Immunol. 2025; 16:1499397.

PMID: 40051632 PMC: 11883826. DOI: 10.3389/fimmu.2025.1499397.

A 10-year bibliometric analysis in the field of osteosarcoma treatment from 2014 to 2023.

Shen Y, Shao X, Chen J, Tang X Discov Oncol. 2025; 16(1):255.

PMID: 40019638 PMC: 11871176. DOI: 10.1007/s12672-025-02007-2.

NK cell depletion in bispecific antibody therapy is associated with lack of HIV control after ART interruption.

Sanchez-Gaona N, Perea D, Curran A, Burgos J, Navarro J, Suanzes P Commun Biol. 2025; 8(1):236.

PMID: 39953264 PMC: 11829058. DOI: 10.1038/s42003-025-07651-6.

Regulation of NK cell development, maturation, and antitumor responses by the nuclear receptor NR2F6.

Woelk J, Hornsteiner F, Aschauer-Wallner S, Stoitzner P, Baier G, Hermann-Kleiter N Cell Death Dis. 2025; 16(1):77.

PMID: 39920136 PMC: 11806049. DOI: 10.1038/s41419-025-07407-4.

The development and application of chimeric antigen receptor natural killer (CAR-NK) cells for cancer therapy: current state, challenges and emerging therapeutic advances.

Yao P, Liu Y, Huang G, Hao L, Wang R Exp Hematol Oncol. 2024; 13(1):118.

PMID: 39633491 PMC: 11616395. DOI: 10.1186/s40164-024-00583-7.

References

Paust S, Gill H, Wang B, Flynn M, Moseman E, Senman B . Critical role for the chemokine receptor CXCR6 in NK cell-mediated antigen-specific memory of haptens and viruses. Nat Immunol. 2010; 11(12):1127-35. PMC: 2982944. DOI: 10.1038/ni.1953. View

Vitale C, Cottalasso F, Montaldo E, Moretta L, Mingari M . Methylprednisolone induces preferential and rapid differentiation of CD34+ cord blood precursors toward NK cells. Int Immunol. 2008; 20(4):565-75. DOI: 10.1093/intimm/dxn014. View

Fehniger T, Cooper M, Nuovo G, Cella M, Facchetti F, Colonna M . CD56bright natural killer cells are present in human lymph nodes and are activated by T cell-derived IL-2: a potential new link between adaptive and innate immunity. Blood. 2002; 101(8):3052-7. DOI: 10.1182/blood-2002-09-2876. View

Wang H, Smith K . The interleukin 2 receptor. Functional consequences of its bimolecular structure. J Exp Med. 1987; 166(4):1055-69. PMC: 2188729. DOI: 10.1084/jem.166.4.1055. View

Zhang N, Bevan M . Transforming growth factor-β signaling controls the formation and maintenance of gut-resident memory T cells by regulating migration and retention. Immunity. 2013; 39(4):687-96. PMC: 3805703. DOI: 10.1016/j.immuni.2013.08.019. View

Guleria I, Khosroshahi A, Ansari M, Habicht A, Azuma M, Yagita H . A critical role for the programmed death ligand 1 in fetomaternal tolerance. J Exp Med. 2005; 202(2):231-7. PMC: 2213002. DOI: 10.1084/jem.20050019. View

Kobayashi M, Fitz L, Ryan M, Hewick R, Clark S, Chan S . Identification and purification of natural killer cell stimulatory factor (NKSF), a cytokine with multiple biologic effects on human lymphocytes. J Exp Med. 1989; 170(3):827-45. PMC: 2189443. DOI: 10.1084/jem.170.3.827. View

Mackay L, Rahimpour A, Ma J, Collins N, Stock A, Hafon M . The developmental pathway for CD103(+)CD8+ tissue-resident memory T cells of skin. Nat Immunol. 2013; 14(12):1294-301. DOI: 10.1038/ni.2744. View

Kundig T, Schorle H, Bachmann M, Hengartner H, Zinkernagel R, Horak I . Immune responses in interleukin-2-deficient mice. Science. 1993; 262(5136):1059-61. DOI: 10.1126/science.8235625. View

10.

Minagawa M, Watanabe H, Miyaji C, Tomiyama K, Shimura H, Ito A . Enforced expression of Bcl-2 restores the number of NK cells, but does not rescue the impaired development of NKT cells or intraepithelial lymphocytes, in IL-2/IL-15 receptor beta-chain-deficient mice. J Immunol. 2002; 169(8):4153-60. DOI: 10.4049/jimmunol.169.8.4153. View

11.

Lotzova E, Savary C, Herberman R . Induction of NK cell activity against fresh human leukemia in culture with interleukin 2. J Immunol. 1987; 138(8):2718-27. View

12.

Pien G, Satoskar A, Takeda K, Akira S, Biron C . Cutting edge: selective IL-18 requirements for induction of compartmental IFN-gamma responses during viral infection. J Immunol. 2000; 165(9):4787-91. DOI: 10.4049/jimmunol.165.9.4787. View

13.

Flanagan J, Chan D, Leder P . Transmembrane form of the kit ligand growth factor is determined by alternative splicing and is missing in the Sld mutant. Cell. 1991; 64(5):1025-35. DOI: 10.1016/0092-8674(91)90326-t. View

14.

Toksoz D, Zsebo K, Smith K, Hu S, Brankow D, Suggs S . Support of human hematopoiesis in long-term bone marrow cultures by murine stromal cells selectively expressing the membrane-bound and secreted forms of the human homolog of the steel gene product, stem cell factor. Proc Natl Acad Sci U S A. 1992; 89(16):7350-4. PMC: 49707. DOI: 10.1073/pnas.89.16.7350. View

15.

Yang Y, Han Q, Hou Z, Zhang C, Tian Z, Zhang J . Exosomes mediate hepatitis B virus (HBV) transmission and NK-cell dysfunction. Cell Mol Immunol. 2016; 14(5):465-475. PMC: 5423088. DOI: 10.1038/cmi.2016.24. View

16.

Mao Y, van Hoef V, Zhang X, Wennerberg E, Lorent J, Witt K . IL-15 activates mTOR and primes stress-activated gene expression leading to prolonged antitumor capacity of NK cells. Blood. 2016; 128(11):1475-89. PMC: 5025899. DOI: 10.1182/blood-2016-02-698027. View

17.

Hsieh C, Macatonia S, Tripp C, Wolf S, OGarra A, Murphy K . Development of TH1 CD4+ T cells through IL-12 produced by Listeria-induced macrophages. Science. 1993; 260(5107):547-9. DOI: 10.1126/science.8097338. View

18.

Morris R, Chong L, Wilkinson G, Wang E . A high-efficiency system of natural killer cell cloning. J Immunol Methods. 2005; 307(1-2):24-33. PMC: 2843082. DOI: 10.1016/j.jim.2005.08.015. View

19.

Wilkens J, Male V, Ghazal P, Forster T, Gibson D, Williams A . Uterine NK cells regulate endometrial bleeding in women and are suppressed by the progesterone receptor modulator asoprisnil. J Immunol. 2013; 191(5):2226-35. PMC: 3843142. DOI: 10.4049/jimmunol.1300958. View

20.

Ihle J . Cytokine receptor signalling. Nature. 1995; 377(6550):591-4. DOI: 10.1038/377591a0. View